Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered question first ministerially corrected answering member label attachment file name title previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1132035

registered interest
date	13/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Primary Care Networks
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the requirements for primary care networks to engage with the local community will be.
tabling member constituency	Newton Abbot
tabling member printed	Anne Marie Morris
uin	264406
answer	answer is ministerial correction date of answer 18/06/2019 answer text <p><ins class="ministerial"> <p><ins class="ministerial">Primary Care Networks (PCNs) are a new way for primary and community service organisations to work together. For PCNs to be successful they will need to work in partnership with local people and the communities they serve. Legal duties which currently apply to NHS service providers - including general practitioner practices - and commissioners around engagement and consultation will continue to be valid for PCNs.</ins></p></ins></p><p><del class="ministerial">NHS England and NHS Improvement, together with the National Institute for Health and Care Excellence, is developing a ’commercial framework’ setting out the parameters for the commercial approach for medicines in the health service in England.</del></p><p><del class="ministerial">The commercial framework will support a single, transparent, robust and integrated pricing and market access process, and is being tested with and informed through consultation with stakeholders including the Association of the British Pharmaceutical Industry.</del></p><p><del class="ministerial">In preparation for public consultation in the coming months, NHS England is actively engaging with industry trade bodies and health system partners, in the first instance, to outline progress on the development of the commercial framework. The consultation on the draft framework is anticipated to be launched in Quarter 3 2019 with consultation events to be held in Manchester and London, and implementation of the commercial framework is expected to follow.</del></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 18/06/2019 16:34:05 question first ministerially corrected 19/06/2019 08:36:30 answering member 4455 label Biography information for Seema Kennedy previous answer version 123829 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
tabling member	4249 label Biography information for Anne Marie Morris

1129191

registered interest
date	03/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescription Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many prescriptions of (a) individual benzodiazepine drugs and (b) individual antidepressants were dispensed in the community in 2018.
tabling member constituency	Bristol North West
tabling member printed	Darren Jones
uin	259400
answer	answer is ministerial correction date of answer 11/06/2019 answer text <p>Information on the number of prescription items from the Prescription Cost Analysis system for benzodiazepines and antidepressants written in the United Kingdom and dispensed in the community in England, for the year 2018 can be found in the attached tables.</p><p>The data available is at prescription item level by presentation. Prescriptions are prescribed either by a paper prescription form or via an Electronic Prescription Service message. Each single item written on the form is counted as a prescription item. No information is available for those prescriptions written but not dispensed.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 11/06/2019 16:51:00 question first ministerially corrected 12/06/2019 14:34:05 answering member 4455 label Biography information for Seema Kennedy attachment 1 file name PQ259400 table formatted.docx title Prescription data benzodiazipines & antidepressant previous answer version 122124 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
tabling member	4621 label Biography information for Darren Jones

1128442

registered interest
date	23/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will publish the evidence (a) his Department and (b) the Department for International Trade holds on growing a market for prescribed medicinal cannabis.
tabling member constituency	Hemel Hempstead
tabling member printed	Sir Mike Penning
uin	257706
answer	answer is ministerial correction date of answer 10/06/2019 answer text <p><ins class="ministerial"> <p><ins class="ministerial">The Department for International Trade and the Department of Health and Social Care are not specifically collecting data on the growth of the market for cannabis based products for medicinal use in the United Kingdom.</ins></p><p><ins class="ministerial">However, data from the Medicines and Healthcare products Regulatory Agency (MHRA) shows growing numbers of import notifications for medicinal cannabis and the Home Office has received increased numbers of licence applications.</ins></p><p><ins class="ministerial">In addition, UK companies exporting these products and foreign companies looking to invest in the UK have full access to government support, where they have the necessary authorisations from the MHRA and Home Office and a relevant Export Licence.</ins></p></ins></p><p><del class="ministerial">An initial impact assessment was published alongside The Misuse of Drugs (Amendments) (Cannabis and Licence Fees) (England, Wales and Scotland) Regulations 2018. This can be viewed at the following link:</del></p><p><del class="ministerial"><a href="http://www.legislation.gov.uk/uksi/2018/1055/impacts" target="_blank">http://www.legislation.gov.uk/uksi/2018/1055/impacts</a></del></p><p><del class="ministerial">This set out the approach that the Government proposed to take in assessing the costs and benefits of the change in the law at a population level, with regard to the rescheduling of cannabis-based products for medicinal use (CBPM). This framework included potential savings in treatment costs, giving the example of patients with severe epilepsy for whom medicinal use of cannabis could reduce the frequency of seizures and reduce the number of related hospital admissions. This was an initial framework for assessing this policy and as we develop our knowledge in this area, both on the costs and the potential benefits, we can revisit and refine these assessments.</del></p><p><del class="ministerial">In the meantime, the National Institute for Health and Care Excellence (NICE) is developing clinical guidelines on the appropriate use of CBPM based on the best available evidence, and the National Institute for Health Research is funding further clinical research on this. More information is available at the following link:</del></p><p><del class="ministerial"><a href="https://www.nihr.ac.uk/funding-and-support/documents/themed-calls/cannabis-based%20products/cannabis-based-products-brief.pdf" target="_blank">https://www.nihr.ac.uk/funding-and-support/documents/themed-calls/cannabis-based%20products/cannabis-based-products-brief.pdf</a></del></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 10/06/2019 13:18:03 question first ministerially corrected 11/06/2019 11:31:21 answering member 4455 label Biography information for Seema Kennedy previous answer version 121340 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
tabling member	1528 label Biography information for Sir Mike Penning

1126321

registered interest
date	13/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Gender Dysphoria: Children
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government whether they intend to publish the results of the research project started in 2011 by the NHS Gender Identity Development Service Early pubertal suppression in a carefully selected group of adolescents with gender identity disorder; and if not, whether they will arrange for the data gathered by that study to be made available to other researchers.
tabling member printed	Lord Lucas
uin	HL15681
answer	answer is ministerial correction date of answer 22/05/2019 answer text <p>The research is an ethically approved study being carried out by the Tavistock and Portman NHS Foundation Trust since 2011, which is the largest provider of services for the alleviation of gender dysphoria in the United Kingdom.</p><p>The study will evaluate early pubertal suppression in a carefully selected group of adolescents with a clinical diagnosis of gender dysphoria. There are 44 young people taking part in the study.</p><p>The Tavistock and Portman NHS Foundation Trust has plans to publish the data <ins class="ministerial">on the blocker and cross-sex hormones, for those who were appropriate for this, as</ins><del class="ministerial">once</del> all of the young people in the study have reached <ins class="ministerial">this</ins><del class="ministerial">the</del> stage<ins class="ministerial">.</ins> <del class="ministerial">when a clinical decision is made about moving from pubertal suppressants to cross-sex hormones, which the Trust expects to occur in the next 12 months.</del></p> answering member printed Baroness Blackwood of North Oxford question first answered 22/05/2019 14:51:30 question first ministerially corrected 31/07/2019 15:30:59 answering member 4019 label Biography information for Baroness Blackwood of North Oxford previous answer version 119577 answering member printed Baroness Blackwood of North Oxford answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	1879 label Biography information for Lord Lucas

1123445

registered interest
date	26/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Infant Foods
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will publish the (a) dates, (b) attendees and (c) topics of meetings his Department has had with representatives of the formula milk industry in 2018 and 2019 to date.
tabling member constituency	Washington and Sunderland West
tabling member printed	Mrs Sharon Hodgson
uin	247997
answer	answer is ministerial correction date of answer 07/05/2019 answer text <p>The Department has provided details of meetings between Departmental officials with representatives of the formula milk industry. Meetings organised by executive agencies or the Food Standards Agency have not been included. We have not disclosed details of staff attending as they were not Senior Civil Service grade. The information is shown in the following table.</p><table><tbody><tr><td><p>Date</p></td><td><p>Organisation</p></td><td><p>Discussion</p></td></tr><tr><td><p>26 February 2018</p></td><td><p>Nestle</p></td><td><p>Presentation on action on sustainable diets</p></td></tr><tr><td><p>26 March 2018</p></td><td><p>Nestle</p></td><td><p>Phone call</p></td></tr><tr><td><p>25 April 2018</p></td><td><p>Danone and Nutrica</p></td><td><p>Early Years Nutrition Partnership</p></td></tr><tr><td><p>6 June 2018</p></td><td><p>British Specialist Nutrition Association (BSNA), Nestle, Nutrica</p></td><td><p>Notifications for Foods for Special Medical Purposes</p></td></tr><tr><td><p>22 June 2018</p></td><td><p>Nestle</p></td><td><p>Planning for visit</p></td></tr><tr><td><p>4 July 2018</p></td><td><p>Nestle</p></td><td><p>Visit</p></td></tr><tr><td><p>11 July 2018</p></td><td><p>Danone</p></td><td><p>Aptamil</p></td></tr><tr><td><p>30 July 2018</p></td><td><p>Danone</p></td><td><p>Childhood Obesity Chapter 2</p></td></tr><tr><td><p>14 August 2018</p></td><td><p>Nestle</p></td><td><p>Childhood Obesity Chapter 2</p></td></tr><tr><td><p>22 August 2018</p></td><td><p>BSNA</p></td><td><p>Phone meeting</p></td></tr><tr><td><p>10 September 2018</p></td><td><p>Danone and Nestle</p></td><td><p>Advertising roundtable</p></td></tr><tr><td><p>14 November 2018</p></td><td><p>BSNA</p></td><td><p>Nutrition legislation meeting</p></td></tr><tr><td><p>15 November 201<ins class="ministerial">8</ins><del class="ministerial">9</del></p></td><td><p>Danone</p></td><td><p>Reformulation, Brexit pressure, and Chapter</p></td></tr><tr><td><p>22 November 201<ins class="ministerial">8</ins><del class="ministerial">9</del></p></td><td><p>BSNA</p></td><td><p>Forthcoming CODEX CCNFSDU40</p></td></tr></tbody></table><p> </p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 07/05/2019 16:50:53 question first ministerially corrected 14/05/2019 10:58:49 answering member 4455 label Biography information for Seema Kennedy previous answer version 116720 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
tabling member	1521 label Biography information for Mrs Sharon Hodgson

1088721

registered interest
date	14/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Primary Care Networks
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to NHS England’s document, Investment and evolution: A five-year framework for GP contract reform to implement the NHS Long Term Plan, published on 31 January 2019, what plans his Department has to ensure the integration of local authority-commissioned public health services within the new Primary Care Networks.
tabling member constituency	Kingston upon Hull North
tabling member printed	Diana Johnson
uin	232537
answer	answer is ministerial correction date of answer 19/03/2019 answer text <p>Primary Care Networks (PCNs) are collaborations between general practitioner (GP) practices and a range of other local providers, typically serving a population of between 30,000 and 50,000. The Network Contract Direct Enhanced Service payment for PCNs is in final development and will be published in due course.</p><p> </p><p>It is expected that PCNs should engage with local authorities as a key local partner in the delivery of integrated health and care services in order to support the objectives in the NHS Long Term Plan.</p><p> </p><p>From <del class="ministerial">April</del> <ins class="ministerial">October</ins> 2019, contraception services will no longer be an Additional Service under the Regulations governing the General Medical Services contract but will become part of Essential Services for GP contractors.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/03/2019 16:38:30 question first ministerially corrected 08/04/2019 09:35:05 answering member 4067 label Biography information for Steve Brine previous answer version 108779 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
tabling member	1533 label Biography information for Dame Diana Johnson

1088722

registered interest
date	14/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Primary Care Networks
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to NHS England’s document, Investment and evolution: A five-year framework for GP contract reform to implement the NHS Long Term Plan, published on 31 January 2019, what plans his Department has to ensure the integration of (a) sexual and reproductive health services and (b) contraception provision within the new Primary Care Networks.
tabling member constituency	Kingston upon Hull North
tabling member printed	Diana Johnson
uin	232538
answer	answer is ministerial correction date of answer 19/03/2019 answer text <p>Primary Care Networks (PCNs) are collaborations between general practitioner (GP) practices and a range of other local providers, typically serving a population of between 30,000 and 50,000. The Network Contract Direct Enhanced Service payment for PCNs is in final development and will be published in due course.</p><p> </p><p>It is expected that PCNs should engage with local authorities as a key local partner in the delivery of integrated health and care services in order to support the objectives in the NHS Long Term Plan.</p><p> </p><p>From <del class="ministerial">April</del> <ins class="ministerial">October </ins>2019, contraception services will no longer be an Additional Service under the Regulations governing the General Medical Services contract but will become part of Essential Services for GP contractors.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/03/2019 16:38:30 question first ministerially corrected 08/04/2019 09:35:21 answering member 4067 label Biography information for Steve Brine previous answer version 108780 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
tabling member	1533 label Biography information for Dame Diana Johnson

1088723

registered interest
date	14/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Primary Care Networks
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to NHS England’s document, Investment and evolution: A five-year framework for GP contract reform to implement the NHS Long Term Plan, published on 31 January 2019, whether the new Network Contract DES will require Primary Care Networks to collaborate with local authorities in delivering integrated care to local populations.
tabling member constituency	Kingston upon Hull North
tabling member printed	Diana Johnson
uin	232539
answer	answer is ministerial correction date of answer 19/03/2019 answer text <p>Primary Care Networks (PCNs) are collaborations between general practitioner (GP) practices and a range of other local providers, typically serving a population of between 30,000 and 50,000. The Network Contract Direct Enhanced Service payment for PCNs is in final development and will be published in due course.</p><p> </p><p>It is expected that PCNs should engage with local authorities as a key local partner in the delivery of integrated health and care services in order to support the objectives in the NHS Long Term Plan.</p><p> </p><p>From <del class="ministerial">April</del> <ins class="ministerial">October</ins> 2019, contraception services will no longer be an Additional Service under the Regulations governing the General Medical Services contract but will become part of Essential Services for GP contractors.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/03/2019 16:38:30 question first ministerially corrected 08/04/2019 09:35:13 answering member 4067 label Biography information for Steve Brine previous answer version 108781 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
tabling member	1533 label Biography information for Dame Diana Johnson

1088724

registered interest
date	14/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Primary Health Care: Females
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to NHS England’s document, Investment and evolution: A five-year framework for GP contract reform to implement the NHS Long Term Plan, published 31 January 2019, whether his Department has plans to introduce a national service specification for women’s health including a focus on (a) sexual and reproductive health and (b) contraception.
tabling member constituency	Kingston upon Hull North
tabling member printed	Diana Johnson
uin	232540
answer	answer is ministerial correction date of answer 19/03/2019 answer text <p>The recently published 2019/20 general practitioner (GP) Contract announced seven national service specifications that will be developed for the new Primary Care Networks:</p><p>- Structured Medications Review and Optimisation;</p><p>- Enhanced Health in Care Homes, to implement the vanguard model;</p><p>- Anticipatory Care requirements for high need patients typically experiencing several long term conditions, joint with community services;</p><p>- Personalised Care, to implement the NHS Comprehensive Model;</p><p>- Supporting Early Cancer Diagnosis;</p><p>- Cardiovascular Disease Prevention and Diagnosis; and</p><p>- Tackling Neighbourhood Inequalities.</p><p> </p><p>There are no current plans for an additional service specification on women’s health, as we would expect the health needs of all patients, including women, to be a key consideration in each of the seven service specifications. In addition, under the General Medical Services contract, GP practices must provide essential services that include the provision of appropriate ongoing treatment and care to all of their patients and onward referral where appropriate.</p><p> </p><p>From <del class="ministerial">April</del> <ins class="ministerial">October </ins>2019, contraception services will no longer be an Additional Service under the Regulations governing the General Medical Services contract but will become part of Essential Services for GP contractors.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/03/2019 16:36:54 question first ministerially corrected 08/04/2019 09:34:51 answering member 4067 label Biography information for Steve Brine previous answer version 108777 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
tabling member	1533 label Biography information for Dame Diana Johnson

1086653

registered interest
date	11/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Tomography
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what comparative estimate he has made of the cost to the public purse of providing PET-CT scanning services through a (a) private contractor and (b) a NHS trust.
tabling member constituency	Oxford West and Abingdon
tabling member printed	Layla Moran
uin	230888
answer	answer is ministerial correction date of answer 14/03/2019 answer text <p>The estimated total cost to National Health Service trusts and NHS foundation trusts of providing PET-CT scans <ins class="ministerial">is </ins><ins class="ministerial">approximately £90 million</ins><del class="ministerial">is £29.4 million</del>, with an average unit cost of <ins class="ministerial">approximately £900 </ins><del class="ministerial">£570</del> per examination<ins class="ministerial"> (this includes the cost of both the scan and a standard tracer)</ins>. Costs are not collected nationally by private contractors.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 14/03/2019 16:52:46 question first ministerially corrected 14/05/2019 10:51:18 answering member 4067 label Biography information for Steve Brine previous answer version 107807 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
tabling member	4656 label Biography information for Layla Moran